(Created page with "{{Medical Device |Health Topic=Maternal mortality, |Classification=Preventative |Scope=Prototype |Location=Africa, Asia, South America |Image=Imageneeded.png }} <!-- Please make...") |
(Normalize) |
||
(25 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Medical | [[File:Poinerm.gif|thumb]] | ||
| | |||
| | {{Medical equipment data | ||
| | | health-topic = Maternal mortality | ||
| | | health-classification = Preventative | ||
| | }} | ||
{{Project data | |||
| made = No | |||
| replicated = No | |||
| location = Perth, Australia | |||
}} | }} | ||
==Detailed description of the solution== | == Problem being addressed == | ||
Women in developing nations often do not have access to contraceptives, and in the case that they do, may find it difficult to adhere to tedious guidelines on a regular basis. Essentially, there is a need for easy-to-use, cost-effective contraceptives that do not require regular maintenance or effort. | |||
== Detailed description of the solution == | |||
This innovative drug delivery system is a subcutaneous biosynthetic bone-like material made of calcium minerals that, once implanted, can deliver contraceptives at regular intervals in a sustained manner for several months. | This innovative drug delivery system is a subcutaneous biosynthetic bone-like material made of calcium minerals that, once implanted, can deliver contraceptives at regular intervals in a sustained manner for several months. | ||
==Designed by== | == Designed by == | ||
*Designed by: This device is currently being developed by Gérrard Poinern of Murdoch University in Australia. | |||
*Manufacturer location: Murdoch University in Perth, Australia | * Designed by: This device is currently being developed by Gérrard Poinern of Murdoch University in Australia. | ||
* Manufacturer location: Murdoch University in Perth, Australia | |||
== When and where it was tested/implemented == | |||
A research group is currently developing the technology to be feasible, and if successful, will collaborate with a drug company to begin human trials. | A research group is currently developing the technology to be feasible, and if successful, will collaborate with a drug company to begin human trials. | ||
==Funding Source== | == Funding Source == | ||
This device received funding from the Grand Challenges Exploration Grant from the Bill & Melinda Gates Foundation. | This device received funding from the Grand Challenges Exploration Grant from the Bill & Melinda Gates Foundation. | ||
==References== | == References == | ||
===Other internally generated reports=== | |||
Murdoch receives $100,000 to develop a contraceptive for third world. (2010, November 10). Murdoch University. | === Other internally generated reports === | ||
Murdoch receives $100,000 to develop a contraceptive for third world. (2010, November 10). Murdoch University. Retrieved February 5, 2013. Link available [http://media.murdoch.edu.au/murdoch-receives-100000-to-develop-a-contraceptive-for-third-world here]. | |||
=== Externally generated reports === | |||
Grand Challenges Explorations: Round 5 Winners Highlights. (n.d.). Bill & Melinda Gates Foundation. Retrieved February 5, 2013. Link available [http://www.grandchallenges.org/pages/default.aspx here]. | Grand Challenges Explorations: Round 5 Winners Highlights. (n.d.). Bill & Melinda Gates Foundation. Retrieved February 5, 2013. Link available [http://www.grandchallenges.org/pages/default.aspx here]. | ||
{{Page data | |||
| part-of = Global Health Medical Device Compendium | |||
| sdg = SDG03 Good health and well-being | |||
| license = CC-BY-SA-3.0 | |||
| language = en | |||
}} |
Latest revision as of 14:33, 5 October 2022
Problem being addressed[edit | edit source]
Women in developing nations often do not have access to contraceptives, and in the case that they do, may find it difficult to adhere to tedious guidelines on a regular basis. Essentially, there is a need for easy-to-use, cost-effective contraceptives that do not require regular maintenance or effort.
Detailed description of the solution[edit | edit source]
This innovative drug delivery system is a subcutaneous biosynthetic bone-like material made of calcium minerals that, once implanted, can deliver contraceptives at regular intervals in a sustained manner for several months.
Designed by[edit | edit source]
- Designed by: This device is currently being developed by Gérrard Poinern of Murdoch University in Australia.
- Manufacturer location: Murdoch University in Perth, Australia
When and where it was tested/implemented[edit | edit source]
A research group is currently developing the technology to be feasible, and if successful, will collaborate with a drug company to begin human trials.
Funding Source[edit | edit source]
This device received funding from the Grand Challenges Exploration Grant from the Bill & Melinda Gates Foundation.
References[edit | edit source]
Other internally generated reports[edit | edit source]
Murdoch receives $100,000 to develop a contraceptive for third world. (2010, November 10). Murdoch University. Retrieved February 5, 2013. Link available here.
Externally generated reports[edit | edit source]
Grand Challenges Explorations: Round 5 Winners Highlights. (n.d.). Bill & Melinda Gates Foundation. Retrieved February 5, 2013. Link available here.